Skip to main content

Location of Colonies

NIA aged rodent colonies are located at Charles River Laboratories.

All Mice are under contract 16 01i, and are located in barriers R12, K63, and K95

All Rats are under contract 17 04i, and are located in barriers R05, R17 and K81

Notice: change in source of F344 foundation stock

For all previous new F344 colony development, the NIA used foundation stock from the NIH Animal Genetic Resource. This facility was closed around 2004. Unfortunately, the F344 breeding stock from the NIH colony that was sent to the Rat Resource and Research Center would not breed, so this source of F344 stock is lost to us. The last stock we received from the NIH, for the caloric restriction colony, also bred poorly, suggesting an unknown genetic change in the NIH foundation stock. To ensure that we used foundation stock from a source that would likely be available for the long-term and for which the breeding patterns were consistent with F344’s history, we chose the Charles River-derived Fisher rat, F344-cdf.

Before making this decision, we had a genetic comparison done between the F344-nih (n = 18) and F344-cdf (n = 12). On a panel of 106 SNPs spanning all chromosomes, 100 of them were identical between the two colonies (94.3% identity):

  • four markers were fixed for a different allele in F344-cdf from that in F344-nih (chr 1 cM 89.1, chr 2 cM 72.8, chr 4 cM 98.9, chr 10 cM 77.2)
  • one marker was fixed in F344-cdf and segregating in F344-nih (chr 12 cM 27.2)
  • one marker failed in all F344-cdf but worked in all F344-nih (chr 15 cM24.5), suggesting a mutation in the primer region or possibly a deletion in the region

While we cannot be sure how the change in the foundation stock will affect aging phenotypes, we feel that this is the best long-term solution to the loss of the NIH foundation stock. We are developing colonies of F344-nih (using breeding stock from our caloric restricted colony started in 2004) and F344-cdf in parallel so that investigators can compare the two substrains in their assays. Entries of the F344-nih began in the spring of 2013 and will be phased out by the end of 2014 so aged F344-nih will only be available until the end of 2016. Investigators wishing to make such comparisons should plan accordingly. In the beginning, F344-nih will be the default strain shipped unless the order states a specific request; by around 2015, it will switch to F344-cdf being the default strain.

The first cohorts of F344-cdf will be set aside for a lifespan study and the results of that study will be posted here as they become available. If anyone wants to share data comparing F344-cdf to F344-nih, we would be happy to post it here with appropriate citation. To submit comparison data, contact Dr. Francesca Macchiarini.